<DOC>
	<DOCNO>NCT00707915</DOCNO>
	<brief_summary>Benzodiazepines ( BZDs ) report cause negative impact motor well cognitive function , turn could result lethal incident include fall especially elderly . This notwithstanding , trial evaluate feasibility benefit discontinue BZD-derivative hypnotic systematic manner frail population . In 8-week open-label study , examine change motor cognitive function follow discontinuation BZD hypnotic old person . OBJECTIVES &amp; HYPOTHESES 1 . Primary Objective The primary objective examine feasibility discontinue BZD-derivative hypnotic old people . 2 . Secondary Objectives 1 . One secondary objective examine magnitude discontinue BZD-derivative hypnotic stability body . 2 . Another secondary objective examine magnitude discontinue BZD-derivative hypnotic cognitive function . Hypotheses 1 . More 80 % participant complete tolerate study procedure . 2a . Participants show improvement stability body . 2b . Participants show improvement cognitive function globally well specifically attention .</brief_summary>
	<brief_title>Effects Discontinuation Benzodiazepine-derivative Hypnotics Cognitive Motor Functions Elderly Persons</brief_title>
	<detailed_description>Benzodiazepines ( BZDs ) report cause negative impact motor well cognitive function , turn could result lethal incident include fall especially elderly . This notwithstanding , trial evaluate feasibility benefit discontinue BZD-derivative hypnotic systematic manner frail population . In study , examine change motor cognitive function follow discontinuation BZD hypnotic old person . In 8-week open-label study , subject age 50 old receive BZD hypnotic unstable physical illness , neurological disorder recruit . The BZD dose discontinue 4 week weekly 25 % reduction . Following assessment perform baseline 12 hour postdose endpoint : Clinical Stabilometric Platform ( CSP ) , Repeatable Battery Assessment Neuropsychological Status ( RBANS ) Critical Flicker Fusion Test ( CFF ) , Leeds Sleep Evaluation Questionnaire ( LSEQ ) . The CSP measure stability body , eye open closed . All psychotropic agent BZD-derivative hypnotic keep constant throughout study . The dose reduction terminate follow condition fulfil : 1 . Clinical worsen sleep define CGI-Global Improvement score 7 2 . Participant 's request 3 . Clinical decision part physician record independent consult physician In event participant need dose increment anxiety insomnia , dose increase back previous dose , follow rest study period . In addition , use trazodone ( 25-100 mg/day ) allow anytime throughout study period .</detailed_description>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>Male female participant race ethnicity psychiatric diagnosis Age 50 old Having treat BZDderivative hypnotic drug steady dose least 4 week Incapacity follow instruction . Unstable physical illness significant neurological disorder Psychiatric concern raise physician record regard participation study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>age</keyword>
	<keyword>benzodiazepine</keyword>
	<keyword>hypnotic</keyword>
	<keyword>cognition</keyword>
	<keyword>posture</keyword>
</DOC>